• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于 7-酮-DHEA 对体重影响的系统评价。

A systematic review of the impact of 7-keto-DHEA on body weight.

机构信息

Department of Obstetrics and Gynecology, University of Bern, Bern, Switzerland.

Medical Library, University Library Bern, University of Bern, Bern, Switzerland.

出版信息

Arch Gynecol Obstet. 2023 Sep;308(3):777-785. doi: 10.1007/s00404-022-06884-8. Epub 2022 Dec 25.

DOI:10.1007/s00404-022-06884-8
PMID:36566478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10348924/
Abstract

7-Keto-DHEA has been commercially advertised as a dietary supplement to support weight loss. The objective of the present systematic review it to summarize the evidence supporting the use of 7-keto-DHEA in overweight and obese population. The systematic search was conducted in Medline, Embase, Cochrane Library, CINAHL, Web of Science, Scopus, ICTRP, and ClinicalTrials.gov. Additionally, reference lists of eligible studies were considered, and authors of relevant studies were contacted. Two authors independently screened the studies against the inclusion criteria and assessed their risk of bias. In total, 4 out of 686 studies were included in the review. They all held a low risk of bias. Half of them showed a significant reduction in body weight. One study found a decrease in body fat percentage and another one reported a decrease in BMI. Two studies stated an increase in resting metabolic rate. No serious adverse effects were reported. Various possible mechanisms in favor of weight loss are discussed; however, with the evidence currently available, no clear answer can be given regarding 7-keto-DHEA and weight loss. Further studies need to be conducted to clarify the efficacy and safety of this drug before it can be recommended for therapeutic use.

摘要

7-酮去氢表雄酮(7-Keto-DHEA)已被商业宣传为一种膳食补充剂,以支持减肥。本系统评价的目的是总结支持超重和肥胖人群使用 7-酮去氢表雄酮的证据。系统检索了 Medline、Embase、Cochrane 图书馆、CINAHL、Web of Science、Scopus、ICTRP 和 ClinicalTrials.gov。此外,还考虑了合格研究的参考文献列表,并联系了相关研究的作者。两位作者独立筛选了符合纳入标准的研究,并评估了其偏倚风险。总共 686 项研究中有 4 项纳入了综述。它们的偏倚风险都较低。其中一半的研究显示体重显著减轻。一项研究发现体脂百分比下降,另一项研究报告 BMI 下降。两项研究表明静息代谢率增加。没有报告严重的不良反应。讨论了支持减肥的各种可能机制;然而,根据目前的证据,对于 7-酮去氢表雄酮和减肥之间的关系,还不能给出明确的答案。在推荐其用于治疗用途之前,需要进行进一步的研究以阐明该药物的疗效和安全性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d3/10348924/35743f7aada8/404_2022_6884_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d3/10348924/5fdd91fbb9e5/404_2022_6884_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d3/10348924/35743f7aada8/404_2022_6884_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d3/10348924/5fdd91fbb9e5/404_2022_6884_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d3/10348924/35743f7aada8/404_2022_6884_Fig2_HTML.jpg

相似文献

1
A systematic review of the impact of 7-keto-DHEA on body weight.一项关于 7-酮-DHEA 对体重影响的系统评价。
Arch Gynecol Obstet. 2023 Sep;308(3):777-785. doi: 10.1007/s00404-022-06884-8. Epub 2022 Dec 25.
2
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.孕期超重或肥胖女性使用二甲双胍以改善母婴结局。
Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2.
3
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
5
Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms.抗精神病药治疗伴有紧张症症状的精神分裂症谱系障碍。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD013100. doi: 10.1002/14651858.CD013100.pub2.
6
Pregabalin add-on for drug-resistant focal epilepsy.普瑞巴林添加治疗耐药性局灶性癫痫。
Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD005612. doi: 10.1002/14651858.CD005612.pub5.
7
Exercise versus airway clearance techniques for people with cystic fibrosis.运动与气道廓清技术治疗囊性纤维化。
Cochrane Database Syst Rev. 2022 Jun 22;6(6):CD013285. doi: 10.1002/14651858.CD013285.pub2.
8
Rimonabant for overweight or obesity.利莫那班用于治疗超重或肥胖症。
Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD006162. doi: 10.1002/14651858.CD006162.pub2.
9
Interventions for palliative symptom control in COVID-19 patients.干预措施以控制 COVID-19 患者的姑息症状。
Cochrane Database Syst Rev. 2021 Aug 23;8(8):CD015061. doi: 10.1002/14651858.CD015061.
10
Methods for blood loss estimation after vaginal birth.阴道分娩后失血估计方法。
Cochrane Database Syst Rev. 2018 Sep 13;9(9):CD010980. doi: 10.1002/14651858.CD010980.pub2.

引用本文的文献

1
Metabolic-Associated Fatty Liver Disease and Insulin Resistance: A Review of Complex Interlinks.代谢相关脂肪性肝病与胰岛素抵抗:复杂关联综述
Metabolites. 2023 Jun 15;13(6):757. doi: 10.3390/metabo13060757.

本文引用的文献

1
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
2
Breastfeeding and postpartum weight loss.母乳喂养与产后体重减轻。
Curr Opin Clin Nutr Metab Care. 2019 Nov;22(6):413-417. doi: 10.1097/MCO.0000000000000597.
3
Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism.糖皮质激素诱导胰岛素抵抗的机制:聚焦于脂肪组织功能和脂质代谢。
Endocrinol Metab Clin North Am. 2014 Mar;43(1):75-102. doi: 10.1016/j.ecl.2013.10.005.
4
Assessing the quality of randomized controlled trials published in the Journal of Korean Medical Science from 1986 to 2011.评估 1986 年至 2011 年《韩国医学科学杂志》发表的随机对照试验的质量。
J Korean Med Sci. 2012 Sep;27(9):973-80. doi: 10.3346/jkms.2012.27.9.973. Epub 2012 Aug 22.
5
The economic impact of obesity in the United States.美国肥胖症的经济影响。
Diabetes Metab Syndr Obes. 2010 Aug 30;3:285-95. doi: 10.2147/DMSOTT.S7384.
6
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.系统评价与Meta分析的首选报告项目:PRISMA声明。
J Clin Epidemiol. 2009 Oct;62(10):1006-12. doi: 10.1016/j.jclinepi.2009.06.005. Epub 2009 Jul 23.
7
Dehydroepiandrosterone 7alpha-hydroxylation in human tissues: possible interference with type 1 11beta-hydroxysteroid dehydrogenase-mediated processes.人组织中脱氢表雄酮的7α-羟化作用:对1型11β-羟类固醇脱氢酶介导过程的可能干扰。
J Steroid Biochem Mol Biol. 2007 May;104(3-5):326-33. doi: 10.1016/j.jsbmb.2007.03.026. Epub 2007 Mar 24.
8
HUM5007, a novel combination of thermogenic compounds, and 3-acetyl-7-oxo-dehydroepiandrosterone: each increases the resting metabolic rate of overweight adults.HUM5007,一种新型产热化合物组合,以及3-乙酰基-7-氧代脱氢表雄酮:二者均可提高超重成年人的静息代谢率。
J Nutr Biochem. 2007 Sep;18(9):629-34. doi: 10.1016/j.jnutbio.2006.11.008. Epub 2007 Apr 5.
9
Reporting attrition in randomised controlled trials.报告随机对照试验中的失访情况。
BMJ. 2006 Apr 22;332(7547):969-71. doi: 10.1136/bmj.332.7547.969.
10
Dietary supplements marketed for weight loss.用于减肥的膳食补充剂。
Nutr Clin Pract. 2003 Apr;18(2):156-69. doi: 10.1177/0115426503018002156.